Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Co‐operative roles of IL‐4Rα a...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Co‐operative roles of IL‐4Rα and IL‐13Rα1 in the progression of ovarian carcinomas and the survival of ovarian carcinoma patients

Co‐operative roles of IL‐4Rα and IL‐13Rα1 in the progression of ovarian carcinomas and the survival of ovarian carcinoma patients

Bibliographic Details
Main Authors: Won Ku Choi, Usama Khamis Hussein, Asmaa Gamal Ahmed, Junyue Zhang, Kyoung Min Kim, Ae Ri Ahn, Ho Sung Park, See‐Hyoung Park, Dong Hyu Cho, Kyu Yun Jang
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Cancer Communications
Online Access:https://doi.org/10.1002/cac2.12445
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1002/cac2.12445

Similar Items

  • IL-13Rα2 Is Involved in Resistance to Doxorubicin and Survival of Osteosarcoma Patients
    by: Maryam Karamikheirabad, et al.
    Published: (2024-11-01)
  • The Clinical Importance of IL-6, IL-8, and TNF-α in Patients with Ovarian Carcinoma and Benign Cystic Lesions
    by: Weronika Pawlik, et al.
    Published: (2021-09-01)
  • SCRIB Is Involved in the Progression of Ovarian Carcinomas in Association with the Factors Linked to Epithelial-to-Mesenchymal Transition and Predicts Shorter Survival of Diagnosed Patients
    by: Usama Khamis Hussein, et al.
    Published: (2021-03-01)
  • Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex
    by: Maxim A.X. Tollenaere, et al.
    Published: (2023-09-01)
  • IL-36α suppresses proliferation of ovarian cancer cells
    by: Lei Chang, et al.
    Published: (2017-05-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs